MS vs MET
By Alex · Tickerpine
Morgan Stanley vs MetLife, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MS | MET |
|---|---|---|
| Price | $190.65 | $102.65 |
| Market cap | $297.99B | $64.51B |
| P/E ratio | 15.1 | 13.4 |
| ROE | 18.04% | 19.92% |
| Profit margin | 25.63% | 6.21% |
| Revenue growth | 10.80% | 18.20% |
| Dividend yield | 2.41% | 2.31% |
| Beta | 1.22 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MS vs MET in plain English
- MS is the bigger company — about 4.6× the market cap of MET.
- MET is cheaper on earnings (P/E 13.4 vs 15.1).
- MET earns a higher return on equity (20% vs 18%).
- MET is growing revenue faster (18% vs 11%).
- MS has the higher dividend yield (2.41% vs 2.31%).
How would $1,000 have done in each?
MS return calculator
See what $1,000 in Morgan Stanley would be worth today.
MET return calculator
See what $1,000 in MetLife, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.